Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MCRB - Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

MCRB - Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

Seres Therapeutics Inc.

2025-08-06 21:48:01 ET

More on Seres Therapeutics

For further details see:

Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

Stock Information
Company Name: Seres Therapeutics Inc.
Stock Symbol: MCRB
Market: NASDAQ
Website: serestherapeutics.com
Menu
Get MCRB Alerts

News, Short Squeeze, Breakout and More Instantly...